GAMBACORTI PASSERINI CARLO
- U08, Floor: 4, Room: 4-12
- U08, Floor: 4, Room: 4041
Publications
Crippa, V., Fontana, D., Civettini, I., Mologni, L., Piazza, R., Gambacorti Passerini, C., et al. (2024). Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer. Intervento presentato a: AACR Annual Meeting 2024 - April 5 - 10, 2024, San Diego, Ca, Usa. Detail
Crespiatico, I., Zaghi, M., Mastini, C., D'Aliberti, D., Mauri, M., Mercado, C., et al. (2024). First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis. BLOOD, 143(14), 1399-1413 [10.1182/blood.2023021349]. Detail
Villa, M., Geeta, G., Malighetti, F., Mauri, M., Arosio, G., Cordani, N., et al. (2024). Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma. BRITISH JOURNAL OF CANCER [10.1038/s41416-024-02881-7]. Detail
Deodato, M., Frustaci, A., Zappaterra, A., Rapella, A., Gambacorti-Passerini, C., Cairoli, R., et al. (2024). Advances in the understanding of molecular genetics and therapy ofRichter transformation in chronic lymphocytic leukemia. LEUKEMIA & LYMPHOMA [10.1080/10428194.2024.2398660]. Detail
Elli, E., Mauri, M., D’Aliberti, D., Crespiatico, I., Fontana, D., Redaelli, S., et al. (2024). Idiopathic erythrocytosis: a germline disease?. CLINICAL AND EXPERIMENTAL MEDICINE, 24(1) [10.1007/s10238-023-01283-y]. Detail
Research projects
Awards
Awards
- ABILITAZIONE SCIENTIFICA NAZIONALE A PROFESSORE DI I FASCIA, SSD MED015, MIUR, 2013
Research and teaching assignments
- Professore a contratto - Professor of Oncology and hematology, Canada research Chair, Dept of Oncology, Jewish General Hospital, Montreal, Canadà - McGill University, 2003 - 2008
Congresses/Conferences
- Program chair - 5th ERIA meeting, "20 year of anniversary of the discovery of ALK", 2014